Can-Fite BioPharma Ltd. (CANF)
3.28
-0.05
(-1.50%)
USD |
NYAM |
Aug 24, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
Can-Fite BioPharma Price to Book Value : 2.381 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.418 |
| August 20, 2026 | 2.432 |
| August 19, 2026 | 2.527 |
| August 18, 2026 | 2.505 |
| August 17, 2026 | 2.599 |
| August 14, 2026 | 2.469 |
| August 13, 2026 | 2.469 |
| August 12, 2026 | 2.498 |
| August 11, 2026 | 2.403 |
| August 10, 2026 | 2.331 |
| August 07, 2026 | 2.498 |
| August 06, 2026 | 2.585 |
| August 05, 2026 | 2.323 |
| August 04, 2026 | 2.316 |
| August 03, 2026 | 2.302 |
| July 31, 2026 | 2.287 |
| July 30, 2026 | 2.382 |
| July 29, 2026 | 2.323 |
| July 28, 2026 | 2.294 |
| July 27, 2026 | 2.287 |
| July 24, 2026 | 2.316 |
| July 23, 2026 | 2.345 |
| July 22, 2026 | 2.396 |
| July 21, 2026 | 2.454 |
| July 20, 2026 | 2.403 |
| Date | Value |
|---|---|
| July 17, 2026 | 2.469 |
| July 16, 2026 | 2.410 |
| July 15, 2026 | 2.382 |
| July 14, 2026 | 2.338 |
| July 13, 2026 | 2.367 |
| July 10, 2026 | 2.360 |
| July 09, 2026 | 2.374 |
| July 08, 2026 | 2.360 |
| July 07, 2026 | 2.527 |
| July 06, 2026 | 2.759 |
| July 02, 2026 | 2.839 |
| July 01, 2026 | 3.362 |
| June 30, 2026 | 2.156 |
| June 29, 2026 | 2.120 |
| June 26, 2026 | 1.997 |
| June 25, 2026 | 2.135 |
| June 24, 2026 | 2.171 |
| June 23, 2026 | 2.214 |
| June 22, 2026 | 2.222 |
| June 18, 2026 | 2.164 |
| June 17, 2026 | 2.20 |
| June 16, 2026 | 2.178 |
| June 15, 2026 | 2.171 |
| June 12, 2026 | 2.062 |
| June 11, 2026 | 2.069 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.7308 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.802 |
| Galmed Pharmaceuticals Ltd. | 0.2377 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 7.557 |
| Price | 3.28 |
| Earnings Yield | -379.6% |
| Market Cap | 4.298M |